Therapy Area
D2M Biotherapeutics doses first subject in solid tumour treatment trial
The study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical activity of DM919.
The study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical activity of DM919.